Incidence, Prevalence, and Mortality
USMLE Step 1 trap: Confuses incidence (new cases) with prevalence (all existing cases). Incidence measures new cases over time in a disease-free population; prevalence measures all existing cases (new + old) at a point in time.
Incidence, prevalence, and mortality are foundational epidemiology concepts that show up constantly on USMLE Step 1 — not just as definitions, but as reasoning tools. Incidence counts new cases arising in a previously disease-free population over a defined time period. Prevalence counts all existing cases (new and old) at a point in time or over a period. The relationship between them is what the exam really probes: prevalence ≈ incidence × duration. Get that equation in your head and a lot of questions become straightforward.
Mortality rate and case fatality rate (CFR) are a separate but equally tested pair. Students consistently conflate them. Mortality rate is a population-level measure — deaths per total population per time. CFR is a disease-level measure — deaths among those who actually have the diagnosis. A disease can have a low mortality rate (rare disease) but a devastatingly high CFR (kills most of the people who get it). USMLE Step 1 will absolutely try to swap these in a vignette and see if you notice.
The trickiest angle is predicting how an intervention shifts these numbers. Most students assume effective treatment → lower prevalence. That's often backwards. A treatment that keeps people alive longer without curing them increases prevalence because cases accumulate. Only prevention (lowering incidence) or cure (shortening duration) will decrease prevalence. This is the conceptual trap the exam loves most.
A gap in most decks — fewer than half of students in our cohort have cards covering this topic.
Common misconceptions
What the exam tests
- Knowing the precise definitions of incidence and prevalence and correctly applying the relationship prevalence ≈ incidence × disease duration to a given scenario.
- Distinguishing mortality rate (deaths per total population over time) from case fatality rate (deaths per diagnosed cases) and knowing which one reflects disease lethality versus population burden.
- Predicting how a new treatment or cure changes incidence, prevalence, and mortality — especially recognizing that a life-prolonging (but non-curative) treatment raises prevalence rather than lowering it.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →